| Name | Taurolidine |
|---|---|
| Synonyms |
4,4'-Methylenebis(tetrahydro-1,2,4-thiadiazine) 1,1,1',1'-tetraoxide
4,4'-methanediylbis(1,2,4-thiadiazinane) 1,1,1',1'-tetraoxide 2H-1,2,4-Thiadiazine, 4,4'-methylenebis[tetrahydro-, 1,1,1',1'-tetraoxide 4,4'-Methylenebis(tetrahydro-1,2,4-sulfadiazine 1,1-dioxide) 4,4'-Methylenebis(perhydro-1,2,4-thiadiazine 1,1-dioxide) Bis(1,1-dioxoperhydro-1,2,4-thiadiazin-4-yl)methane 4,4'-Methylenebis(1,2,4-thiadiazinane) 1,1,1',1'-tetraoxide Taurolin Taurolidine Tauroline |
| Description | Taurolidine is a broad-spectrum antimicrobial for the prevention of central venous catheter-related infections. Taurolidine has a direct and selective antineoplastic effect on brain tumor cells by the induction of apoptosis[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 471.2±55.0 °C at 760 mmHg |
| Melting Point | 156ºC |
| Molecular Formula | C7H16N4O4S2 |
| Molecular Weight | 284.356 |
| Flash Point | 238.8±31.5 °C |
| Exact Mass | 284.061310 |
| PSA | 115.58000 |
| LogP | -2.55 |
| Vapour Pressure | 0.0±1.2 mmHg at 25°C |
| Index of Refraction | 1.564 |
| RIDADR | NONH for all modes of transport |
|---|---|
| HS Code | 2933990090 |
|
~72%
19388-87-5 |
| Literature: BIOPHORE INDIA PHARMACEUTICALS PVT. LTD.; Pullagurla, Manik Reddy; Rangisetty, Jagadeesh Babu; Dokula, Neelam Naidu Patent: US2013/237700 A1, 2013 ; Location in patent: Paragraph 0028 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |